Reversibility of impaired nasal mucociliary clearance in smokers following a smoking cessation programme

Respirology

Volumn 16, Issue 5, 2011, Pages 849-855

  Ramos, Ercy Mara Cipulo ^a   De Toledo, Alessandra Choqueta ^a   Xavier, Rafaella Fagundes ^a   Fosco, Luciana Cristina ^a   Vieira, Rodolfo Paula ^c   Ramos, Dionei ^a   Jardim, José Roberto ^b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Airway epithelium; Mucociliary transport; Public health; Smoking cessation; Tobacco

Indexed keywords

AMFEBUTAMONE; CARBON MONOXIDE; CARBOXYHEMOGLOBIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EDUCATION; FEMALE; HUMAN; LUNG FUNCTION; MALE; MUCOCILIARY CLEARANCE; MUCOCILIARY TRANSPORT; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; SMOKING; SMOKING CESSATION PROGRAM; TOBACCO DEPENDENCE;

ADULT; AGED; CARBON MONOXIDE; CARBOXYHEMOGLOBIN; CASE-CONTROL STUDIES; CILIA; EXHALATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NASAL MUCOSA; RECOVERY OF FUNCTION; RESPIRATORY FUNCTION TESTS; SMOKING; SMOKING CESSATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 79959896679     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2011.01985.x     Document Type: Article

References (40)

1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006; 3: e442.
2. de Marco R, Accordini S, Marcon A et al. Risk factors for chronic obstructive pulmonary disease in a European cohort of young adults. Am. J. Respir. Crit. Care Med. 2011; 183: 891-7.
3. Houtmeyers E, Gosselink R, Gayan-Ramirez G et al. Regulation of mucociliary clearance in health and disease. Eur. Respir. J. 1999; 13: 1177-88.
4. Foster WM, Langenback EG, Bergofsky EH. Disassociation in the mucociliary function of central and peripheral airways of asymptomatic smokers. Am. Rev. Respir. Dis. 1985; 132: 633-9.
5. Almirall J, Gonzalez CA, Balanzo X et al. Proportion of community acquired pneumonia cases attributable to tobacco smoking. Chest 1999; 116: 375-9. (Pubitemid 29382121)
6. Church DF, Pryor WA. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ. Health Perspect. 1985; 64: 111-26.
7. Brunnemann KD, Hoffmann D. Analytical studies on tobacco-specific nitrosamines in tobacco and tobacco smoke. Crit. Rev. Toxicol. 1991; 21: 235-40.
8. Rodgers PA, Vreman HJ, Dennery PA et al. Sources of carbon monoxide (CO) in biological systems and applications of CO detection technologies. Semin. Perinatol. 1994; 18: 2-10.
9. Vreman HJ, Wong RJ, Sanesi CA et al. Simultaneous production of carbon monoxide and thiobarbituric acid reactive substances in rat tissue preparations by an iron-ascorbate system. Can. J. Physiol. Pharmacol. 1998; 76: 1057-65.
10. Sleigh MA, Blake JR, Liron N. The propulsion of mucus by cilia. Am. Rev. Respir. Dis. 1988; 137: 726-41.
11. Salah B, Dinh Xuan AT, Fouilladieu JL et al. Nasal mucociliary transport in healthy subjects is slower when breathing dry air. Eur. Respir. J. 1988; 1: 852-5.
12. Godtfredsen NS, Holst C, Prescott E et al. Smoking reduction, smoking cessation, and mortality: a 16-year follow-up of 19 732 men and women from The Copenhagen Centre for Prospective Population Studies. Am. J. Epidemiol. 2002; 156: 994-1001.
13. Zhu S, Melcer T, Sun J et al. Smoking cessation with and without assistance: a population-based analysis. Am. J. Prev. Med. 2000; 18: 305-11.
14. Fernández E, Schiaffino A, Borrell C et al. Social class, education, and smoking cessation: long-term follow-up of patients treated at a smoking cessation unit. Nicotine Tob. Res. 2006; 8: 29-36.
15. Middleton ET, Morice AH. Breath carbon monoxide as an indication of smoking habit. Chest 2000; 117: 758-63. (Pubitemid 30152217)
16. Gratziou C. Respiratory, cardiovascular and other physiological consequences of smoking cessation. Curr. Med. Res. Opin. 2009; 25: 535-45.
17. Fagerström KO, Heatherten TF, Kozlowski LT. Nicotine addiction and its assessment. Ear Nose Throat J. 1990; 69: 763-5.
18. Brasil Ministério da Saúde, Instituto Nacional do Câncer. Abordagem e Tratamento do Fumante. Consenso 2001. Rio de Janeiro, 2001.
19. Lee JS, Kim Y, Kim WN et al. Changes in smoking status among current male smokers and factors associated with smoking cessation success. J. Prev. Med. Pub. Health 2006; 39: 339-45.
20. American Thoracic Society. Standardization of spirometry: 1994 update. Am. J. Respir. Crit. Care Med. 1995; 152: 1107-36.
21. Duarte AA, Pereira CAC, Rodrigues SC. Validation of new Brazilian predicted values for forced spirometry in Caucasians and comparison with predicted values obtained using other reference equations. J. Bras. Pneumol. 2007; 33: 527-35.
22. Jarvis M, Belcher M, Vessey C et al. Low cost carbon monoxide monitors in smoking assessment. Thorax 1986; 41: 886-7. (Pubitemid 17171688)
23. Javors MA, Hatch JP, Lamb RJ. Cut-off levels for breath carbon monoxide as a marker for cigarette smoking. Addiction 2005; 100: 159-67. (Pubitemid 40255373)
24. Grandes G, Cortada J, Arrazola A et al. Predictors of long-term outcome of a smoking cessation programme in primary care. Br. J. Gen. Pract. 2003; 53: 101-7.
25. Zhou X, Nonnemaker J, Sherrill B et al. Attempts to quit smoking and relapse: factors associated with success or failure from the ATTEMPT cohort study. Addict. Behav. 2009; 34: 365-73.
26. Dale LC, Glover ED, Sachs DP et al. Bupropion for smoking cessation: predictors of successful outcome. Chest 2001; 119: 1357-64. (Pubitemid 32686015)
27. Ozlu T, Cay M, Akbulut A et al. The facilitating effect of cigarette smoke on the colonization of instilled bacteria into the tracheal lumen in rats and the improving influence of supplementary vitamin E on this process. Respirology 1999; 4: 245-8. (Pubitemid 29434468)
28. Groenewegen KH, Wouters EF. Bacterial infections in patients requiring admission for an acute exacerbation of COPD: a 1-year prospective study. Respir. Med. 2003; 97: 770-7.
29. Swan GE, Hodgkin JE, Roby T et al. Reversibility of airways injury over a 12-month period following smoking cessation. Chest 1992; 101: 607-12.
30. Cosio MG, Hale KA, Niewoehner DE. Morphologic and morphometric effects of prolonged cigarette smoking on the small airways. Am. Rev. Respir. Dis. 1980; 122: 265-71.
31. Slebos DJ, Ryter SW, Choi AM. Heme oxygenase-1 and carbon monoxide in pulmonary medicine. Respir. Res. 2003; 4: 7.
32. Otterbein L, Sylvester SL, Choi AM. Hemoglobin provides protection against lethal endotoxemia in rats: the role of heme oxygenase-1. Am. J. Respir. Cell Mol. Biol. 1995; 13: 595-601.
33. Fukushima T, Okinaga S, Sekizawa K et al. The role of carbon monoxide in lucigenin-dependent chemiluminescence of rat alveolar macrophages. Eur. J. Pharmacol. 1995; 289: 103-7.
34. Camhi SL, Alam J, Otterbein L et al. Induction of heme oxygenase-1 gene expression by lipopolysaccharide is mediated by AP-1 activation. Am. J. Respir. Cell Mol. Biol. 1995; 13: 387-98.
35. Kim YM, Bergonia HA, Müller C et al. Loss and degradation of enzyme-bound heme induced by cellular nitric oxide synthesis. J. Biol. Chem. 1995; 270: 5710-13.
36. Cantoni L, Rossi C, Rizzardini M et al. Interleukin-1 and tumour necrosis factor induce hepatic haem oxygenase. Feedback regulation by glucocorticoids. Biochem. J. 1991; 279: 891-4.
37. Stevens JL, Ratnayake JH, Anders MW. Metabolism of dihalomethanes to carbon monoxide. IV. Studies in isolated rat hepatocytes. Toxicol. Appl. Pharmacol. 1980; 55: 484-9.
38. Zayasu K, Sekizawa K, Okinaga S et al. Increased carbon monoxide in exhaled air of asthmatic patients. Am. J. Respir. Crit. Care Med. 1997; 156: 1140-3.
39. Horvath I, Loukides S, Wodehouse T et al. Comparison of exhaled and nasal nitric oxide and exhaled carbon monoxide levels in bronchiectatic patients with and without primary ciliary dyskinesia. Thorax 2004; 58: 68-72.
40. Giuca MR, Giuggioli E, Metelli MR et al. Effects of cigarette smoke on salivary superoxide dismutase and glutathione peroxidase activity. J. Biol. Regul. Homeost. Agents 2010; 24: 359-66.